Press Releases
17 December 2018
LOS ANGELES--(BUSINESS WIRE)-- CHA-Hollywood Presbyterian Medical Center (CHA-HPMC), a subsidiary of CHA Health Systems (a global leade
Read more...17 December 2018
LAKE ZURICH, Ill.--(BUSINESS WIRE)-- Fresenius Kabi announced today the immediate availability in the United States of the Simplist® Palonosetron Hydrochloride Injection. The Simplist® Palonosetron Hydrochloride Injection is available in a 0.25 mg per 5 mL single dose ready-to-administer prefilled syringe. This press release featu
Read more...17 December 2018
CAMBRIDGE, Mass. & HEMEL HEMPSTEAD, England--(BUSINESS WIRE)-- AVEO Oncology (NASDAQ:AVEO) and EUSA Pharma today announced the presentation of updated interim results from the Phase 2 portion of the TiNivo study, a Phase 1b/2 multicenter trial of oral (PO) tivozanib (FOTIVDA®) in combination with intravenous (IV) nivolumab (OPDIVO®, Bristol-Myers Squibb), an immune checkpoint, or
Read more...17 December 2018
CHICAGO--(BUSINESS WIRE)-- The national nonprofit Responsible Battery Coalition (RBC) has been accepted as an affiliate member of the Joint Center for Energy Storage Research (JCESR), led by the U.S. Department of Energy’s Argonne National Laboratory. JCESR, just renewed by the U.S. Department of Energy for another five years, created an affiliate program that brings together small and large
Read more...ALEXANDRIA, Va.--(BUSINESS WIRE)-- Savi®, an innovator in big data/machine learning analytic solutions, supply chain management software, and sensor technology, today announced th
Read more...17 December 2018
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Axcella Health, a biotechnology company pioneering a new approach to address metabolic dysregulation and h
Read more...17 December 2018
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Axcella Health, a biotechnology company pioneering a new approach to address metabolic dysregulation and h
Read more...PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY) today announced the results of a new analysis from the Phase 3 CheckMate -214 study, demonstra
Read more...17 December 2018
DUBLIN--(BUSINESS WIRE)-- Horizon Pharma plc (Nasdaq: HZNP) today announced that multiple studies demonstrating the extensive burden of uncontrolled gout and its impact on patients will be presented at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting, Oct. 19-24, in Chicago. In addition to the data presentations, Horizon will host an academic l
Read more...ALAMEDA, Calif.--(BUSINESS WIRE)-- Wind River®, a leader in delivering IoT software for
Read more...17 December 2018
RADNOR, Pa.--(BUSINESS WIRE)-- Lincoln Financial Group (NYSE:LNC) partnered recently with North Carolina college students for codeLinc, the company’s fifth annual hackathon-style event in which teams competed to develop applications to help improve operations and efficiency for several local nonprofit organizations. The 24-hour event, held October 6-7, included students from North Caroli
Read more...17 December 2018
MIAMI--(BUSINESS WIRE)-- Ryder System, Inc. (NYSE: R), a leader in commercial
Read more...17 December 2018
WASHINGTON--(BUSINESS WIRE)-- Hunton Andrews Kurth LLP recently represented an energy company in obtaining the first public SAFETY Act certification for an internal enterprise-wide cybersecurity program. Administered by the Department of Homeland Security (DHS), the Supporting Anti-Terrorism by Fostering Effective Technologies Act of 2002, more commonly known as SAFETY Act, protects the reputa
Read more...17 December 2018
NOVI, Mich.--(BUSINESS WIRE)-- High-speed robotic leak-detection systems are expected to take the place of many slower, more conventional test methods used by automakers and their suppliers over the next several years. “The need for modern, high-speed, but accurate test methods has increased dramatically in recent years along with a growing interest in electric vehicles,” said Thomas Park
Read more...17 December 2018
PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) today announced four-year data from the Phase 3 CheckMate -067 clinical trial – the lon
Read more...